We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Medis

News List

BIAL and Medis entered into a partnership for innovative medicines for the central nervous system firstwordpharma
July 20, 2021
BIAL and Medis, d.o.o. announce that they have entered into an exclusive partnership on two BIAL's proprietary drugs: Zebinix® (eslicarbazepine acetate) and Ongentys® (opicapone).
Teva attracts attention from pharma, private equity for $500M sale of Medis fiercepharma
September 14, 2018
Teva has been working to pay down tens of billions of dollars of debt since it purchased Allergan’s generics suite for more than $40 billion. Now, the company's Medis unit has attracted attention from industry players and private equity firms, according t